Last reviewed · How we verify

NCT04197245

Efficacy of Saline Injection Therapy in Atrophic Acne Scars

Completed EARLY_PHASE1 Last updated 28 January 2020
What this trial tests

EARLY_PHASE1 trial testing saline injection therapy in post-acne atrophic scars in Atrophic in 49 participants. Completed in 31 July 2019.

Timeline
1 January 2019
Primary endpoint
31 July 2019
31 July 2019

Quick facts

Lead sponsorJinnah Postgraduate Medical Centre
PhaseEARLY_PHASE1
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment49
Start date1 January 2019
Primary completion31 July 2019
Estimated completion31 July 2019
Sites1 location across Pakistan

Drugs / interventions tested

Conditions studied

Sponsor

Jinnah Postgraduate Medical Centre — full company profile →

Who can join

Adults 15 to 35, any sex, with Atrophic or Scars. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of the study was to determine the efficacy of saline injection in post-acne atrophic scars on face. All patients with mild, moderate \& severe post-acne atrophic scars, above age of 15 years without any co-morbid conditions were included in the study. After giving local anesthesia, the isotonic saline solution has been administered intra- and sub-dermally in post-acne atrophic scars on face. The sessions were done weekly, for 12 weeks. The results were assessed by the photographs, sharquie scoring system \& Dermatology Life Quality Index score at the start and at the end of the treatment. SPSS 23 was used to analyze the data. The analysis of data showed that the response of saline injection was significant in mild and moderate scars, without any significant side effects.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Jinnah Postgraduate Medical Centre trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04197245.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing